Efficacy and safety of adjunctive perampanel for the treatment of refractory partial seizures: A pooled analysis of three phase <scp>III</scp> studies

Abstract

Perampanel reduced partial seizure frequency and improved responder rates compared with placebo, with an acceptable tolerability profile.